Paroxetine mesylate

甲磺酸帕罗西汀

Report date: 2022/02/21 14:34:31
NME

Base Information

Drug NameParoxetine mesylate
Drug Alias Name帕罗西汀甲磺酸盐Paroxetine MesilateBrisdelleMesafemEuplix +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin transporter inhibitors
TargetsSerotonin transporter
Therapy Area/IndicationsVasomotor symptomMenopausal symptomsStress Disorders, Post-Traumatic +[11] 
Global Approved IndicationsDepressive Disorder, MajorPanic DisorderObsessive-Compulsive Disorder +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2003/07/03
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSynthon Bv
China Registration ClassN/A

Develop Information

Active CompaniesLegacy Pharma Inc
Inactive CompaniesGlaxosmithkline PlcYale UniversityNoven Therapeutics Llc +[5] 
Active IndicationsVasomotor symptom
Inactive IndicationsMenopausal symptomsStress Disorders, Post-TraumaticDepressive Disorder, Major +[10] 

Other Information

ATC CodeN06AB05
Related LinksWikipediaDrugBankKEGG